Saturday, October 6, 2018: 2:00 PM-3:15 PM
Room: W 2002
Tracks: Adult ID, Epidemiology and Infection Control, HIV-STD-TB, Investigative ID, Pediatric ID, Trainee
Moderators:
Angela P. Campbell, MD, MPH, FPIDS, FIDSA, Centers for Disease Control and Prevention
and
Janet Englund, MD, FIDSA, Seattle Children's Hospital
Presentations:
2:00 PM
Individual Patient-Level Data Meta-Analysis of Live Attenuated and Inactivated Influenza Vaccine Effectiveness among US Children, 2013-14 through 2015-16
Jessie Chung, MPH;
Brendan Flannery, PhD;
Rodolfo Begue, MD;
Herve Caspard, MD, ScD;
Laurie Demarcus, MPH;
Ashley Fowlkes, MPH;
Geeta Kersellius, MPH, MBA;
Andrea Steffens, MPH;
Alicia M. Fry, MD, MPH
2:15 PM
Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine
Sybil Tasker, MD, MPH, FIDSA;
Vyjayanthi Krishnan, PhD;
Stephan Bart, MD;
Anvar Suyundikov, PhD;
Peta-Gay Booth, MD;
Anna Wight O'Rourke, MS;
Jianfeng Zhang, PhD;
Bertrand Georges, PhD;
Scot Roberts, PhD
2:45 PM
Retrospective Evaluation of Mismatch from Egg-based Isolation of Influenza Strains Compared to Cell-based Isolation and the Possible Implications for Vaccine Effectiveness
S Rajaram, MD, MRCPCH, MFPM, MBA;
Josephine Van Boxmeer, MPhil;
Brett Leav, MD;
Pirada Suphaphiphat, PhD;
Ike Iheanacho, MBBS, BSc;
Kristin Kistler, PhD
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
